HLA DR-DQ-encoded genetic determinants of childhood-onset type 1 diabetes in Finland: An analysis of 622 nuclear families

:  The diabetes predisposing effect of HLA genes is defined by a complex interaction of various haplotypes. We analyzed the disease association of HLA DRB1‐DQA1‐DQB1 genotypes in a large nuclear family cohort (n = 622) collected in Finland. Using the affected family based artificial control approach...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Tissue antigens 2003-08, Vol.62 (2), p.162-169
Hauptverfasser: Hermann, R., Turpeinen, H., Laine, A.P., Veijola, R., Knip, M., Simell, O., Sipilä, I., Åkerblom, H.K., Ilonen, J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung::  The diabetes predisposing effect of HLA genes is defined by a complex interaction of various haplotypes. We analyzed the disease association of HLA DRB1‐DQA1‐DQB1 genotypes in a large nuclear family cohort (n = 622) collected in Finland. Using the affected family based artificial control approach we aimed at characterizing all detectable disease‐specific HLA haplotype and genotype effects. The DRB1*0401‐DQB1*0302 haplotype was the most prevalent disease susceptibility haplotype in the Finnish population followed by (DR3)‐DQA1*05‐DQB1*02 and DRB1*0404‐DQB1*0302. DRB1*0405‐DQB1*0302 conferred the highest disease risk, although this haplotype was very rare. The DRB1*04‐DQB1*0304 was also associated with increased disease risk, an effect detected for the first time in the Finnish population. The following haplotypes showed significant protection from the disease and are listed in decreasing order of the strength of their effect: (DR7)‐DQA1*0201‐DQB1*0303, (DR14)‐DQB1*0503, (DR15)‐DQB1*0602, DRB1*0403‐DQB1*0302, (DR13)‐DQB1*0603, (DR11/12/13)‐DQA1*05‐DQB1*0301, (DR1)‐DQB1*0501. In addition to the DRB1*0401/0404‐DQB1*0302/(DR3)‐DQA1*05‐DQB1*02 genotype and DRB1*04‐DQB1*0302 homozygous genotypes, heterozygous combinations DRB1*0401‐DQB1*0302/(DR13)‐DQB1*0604, ∼/(DR8)‐DQB1*04, ∼/(DR9)‐DQA1*03‐DQB1*0303, ∼/(DR1)‐DQB1*0501 and ∼/(DR7)‐DQA1*0201‐DQB1*02 were also disease‐associated. As a new finding in this population, the (DR3)‐DQA1*05‐DQB1*02 homozygous and (DR3)‐DQA1*05‐DQB1*02/(DR9)‐DQA1*03‐DQB1*0303 heterozygous genotypes conferred disease susceptibility. Similarly, the DRB1*0401‐DQB1*0302/(DR13)‐DQB1*0603 genotype was disease predisposing, implying that DQB*0603‐mediated protection from diabetes is not always dominant. Comparison of our findings with published data from other populations indicates a significant disease‐specific heterogeneity of the (DR8)‐DQB1*04, (DR7)‐DQA1*0201‐DQB1*02 and (DR3)‐DQA1*05‐DQB1*02 haplotypes.
ISSN:0001-2815
1399-0039
DOI:10.1034/j.1399-0039.2003.00071.x